FunPep Company Limited 4881Short Interest
Estimated short interest in FunPep Company Limited (4881) is 0.92% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Nomura International plc.
Estimated short interest
0.92%
±0.00%
Estimated position (shares)
469,300
As of 2026-11-18
Holders (0.5% or more)
1 firms
885 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 1 institutions whose last report is more than a year old (0.50% in total). It also excludes 9 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2023-02-10 |
|---|---|
| Latest disclosure | 2026-10-07 (MERRILL LYNCH INTERNATIONAL, 0.49%) |
| Reporting institutions | 13 firms (885 reports) |
| Peak estimated short interest | 9.71% (2024-09-02, 7 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Nomura International plc
- Morgan Stanley MUFG Securities Co., Ltd.
- UBS AG
- MERRILL LYNCH INTERNATIONAL
- Barclays Capital Securities Ltd
- Others
0.92%
Estimated short interest, 2026-11-18
Nomura International plc0.92%
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-10-06 | Nomura International plc | Position 469,300 shares | Ratio 0.92% | ▲0.03% | Holding |
| 2023-08-10 | BNP Paribas Arbitrage SNC | Position 121,000 shares | Ratio 0.50% | ▲0.05% | No report for 1+ year |
| 2026-10-07 | MERRILL LYNCH INTERNATIONAL | Position 253,000 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-06-04 | JPM Securities Japan Co Ltd. | Position 248,000 shares | Ratio 0.49% | ▼0.05% | Below 0.5% |
| 2026-08-17 | Citigroup Global Markets Limited | Position 245,900 shares | Ratio 0.48% | ▼0.03% | Below 0.5% |
| 2026-02-12 | UBS AG | Position 185,100 shares | Ratio 0.45% | ▼0.28% | Below 0.5% |
| 2026-08-21 | Barclays Capital Securities Ltd | Position 223,400 shares | Ratio 0.44% | ▼0.14% | Below 0.5% |
| 2024-03-18 | BNP Paribas Financial Markets SNC formerly known as BNP Paribas Arbitrage SNC | Position 102,800 shares | Ratio 0.42% | ▼0.08% | Below 0.5% |
| 2026-03-13 | Morgan Stanley MUFG Securities Co., Ltd. | Position 163,100 shares | Ratio 0.39% | ▼0.11% | Below 0.5% |
| 2024-09-09 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 105,700 shares | Ratio 0.35% | ▼0.16% | Below 0.5% |
| 2026-04-13 | GOLDMAN SACHS INTERNATIONAL | Position 143,600 shares | Ratio 0.32% | ▼0.47% | Below 0.5% |
| 2025-05-09 | XTX Markets Pte Ltd | Position 0 shares | Ratio 0.00% | ▼0.66% | Closed |
| 2026-06-11 | Mizuho Securities Co., Ltd. | Position 0 shares | Ratio 0.00% | ▼0.71% | Closed |
Disclosure History 885 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-10-07 | MERRILL LYNCH INTERNATIONAL | Position 253,000 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-10-06 | Nomura International plc | Position 469,300 shares | Ratio 0.92% | ▲0.03% | — |
| 2026-10-02 | MERRILL LYNCH INTERNATIONAL | Position 257,500 shares | Ratio 0.50% | ▼0.02% | — |
| 2026-09-30 | MERRILL LYNCH INTERNATIONAL | Position 267,400 shares | Ratio 0.52% | ▼0.02% | — |
| 2026-09-29 | MERRILL LYNCH INTERNATIONAL | Position 275,900 shares | Ratio 0.54% | ▼0.02% | — |
| 2026-09-28 | MERRILL LYNCH INTERNATIONAL | Position 284,900 shares | Ratio 0.56% | ▼0.02% | — |
| 2026-09-24 | Nomura International plc | Position 451,100 shares | Ratio 0.89% | ▼0.08% | — |
| 2026-09-24 | MERRILL LYNCH INTERNATIONAL | Position 297,900 shares | Ratio 0.58% | ▼0.02% | — |
| 2026-09-17 | MERRILL LYNCH INTERNATIONAL | Position 308,900 shares | Ratio 0.60% | ▼0.01% | — |
| 2026-09-16 | MERRILL LYNCH INTERNATIONAL | Position 310,200 shares | Ratio 0.61% | ▼0.01% | — |
| 2026-09-11 | MERRILL LYNCH INTERNATIONAL | Position 315,400 shares | Ratio 0.62% | ▲0.01% | — |
| 2026-09-10 | MERRILL LYNCH INTERNATIONAL | Position 313,200 shares | Ratio 0.61% | ▼0.01% | — |
| 2026-09-02 | Nomura International plc | Position 496,100 shares | Ratio 0.97% | ▼0.03% | — |
| 2026-09-01 | Nomura International plc | Position 509,100 shares | Ratio 1.00% | ▲0.01% | — |
| 2026-08-31 | Nomura International plc | Position 504,600 shares | Ratio 0.99% | ▼0.03% | — |
| 2026-08-31 | MERRILL LYNCH INTERNATIONAL | Position 318,200 shares | Ratio 0.62% | ▼0.01% | — |
| 2026-08-28 | Nomura International plc | Position 519,900 shares | Ratio 1.02% | ▲0.04% | — |
| 2026-08-27 | Nomura International plc | Position 501,500 shares | Ratio 0.98% | ▼0.05% | — |
| 2026-08-21 | Barclays Capital Securities Ltd | Position 223,400 shares | Ratio 0.44% | ▼0.14% | Below 0.5% |
| 2026-08-20 | Nomura International plc | Position 525,900 shares | Ratio 1.03% | ▼0.07% | — |
| 2026-08-19 | Nomura International plc | Position 561,000 shares | Ratio 1.10% | ▲0.07% | — |
| 2026-08-18 | Nomura International plc | Position 523,200 shares | Ratio 1.03% | ▲0.06% | — |
| 2026-08-17 | Nomura International plc | Position 496,100 shares | Ratio 0.97% | ▼0.04% | — |
| 2026-08-17 | Citigroup Global Markets Limited | Position 245,900 shares | Ratio 0.48% | ▼0.03% | Below 0.5% |
| 2026-08-17 | Barclays Capital Securities Ltd | Position 294,200 shares | Ratio 0.58% | ▼0.11% | — |
| 2026-08-14 | Barclays Capital Securities Ltd | Position 354,200 shares | Ratio 0.69% | ▼0.20% | — |
| 2026-08-13 | Nomura International plc | Position 512,700 shares | Ratio 1.01% | ▲0.03% | — |
| 2026-08-12 | Nomura International plc | Position 501,600 shares | Ratio 0.98% | ▼0.09% | — |
| 2026-08-10 | MERRILL LYNCH INTERNATIONAL | Position 319,200 shares | Ratio 0.63% | ▲0.01% | — |
| 2026-08-07 | MERRILL LYNCH INTERNATIONAL | Position 318,400 shares | Ratio 0.62% | ▲0.01% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Solasia Pharma K.K.4597 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Delta-Fly Pharma,Inc.4598 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| StemRIM Inc.4599 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| MediciNova,Inc.4875 | Standard Market(Foreign) | Pharmaceutical | Pharmaceutical | |
| CellSource Co.,Ltd.4880 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| Perseus Proteomics Inc.4882 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Modalis Therapeutics Corporation4883 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kringle Pharma,Inc.4884 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| MUROMACHI CHEMICALS INC.4885 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| ASKA Pharmaceutical Holdings Co.,Ltd.4886 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |